Regulations.gov document
NDI 676 Creatyl-L-Glutamine from Vital Pharmaceuticals Inc. Re Background Material…
Supporting & Related Material · FDA-2011-S-0933 · posted Jul 24, 2014
Key facts
| Document ID | FDA-2011-S-0933-0007 |
|---|---|
| Title | NDI 676 Creatyl-L-Glutamine from Vital Pharmaceuticals Inc. Re Background Material DiPasquale, Amino Acids and Proteins for the Athlete Attachment 6 |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2011-S-0933 |
| Posted | Jul 24, 2014 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: